ICOS co-stimulation

Summary
Organism
Homo sapiens (human)
Reactome
R-HSA-9927354
PubChem
R-HSA-9927354
Description
  • ICOS (Inducible T-cell COStimulator) is a critical costimulatory receptor that enhances T cell responses following initial activation. Unlike CD28, which is constitutively expressed on naive T cells, ICOS expression is induced upon T cell activation. Both ICOS and CD28 engage class IA phosphatidylinositol 3-kinase (PI3K), leading to the production of phosphatidylinositol 3,4,5-trisphosphate (PIP3) and activation of downstream signaling pathways, including AKT. However, ICOS signaling is distinguished by a stronger induction of PIP3 production and more robust AKT phosphorylation compared to CD28 signaling (Fos et al. 2008). This enhanced signaling through ICOS contributes to its unique role in promoting T cell survival, cytokine production, and differentiation, particularly in the context of T follicular helper (Tfh) cell development and function (Dong et al. 2001). Despite these similarities, detailed knowledge about ICOS-specific downstream signaling pathways remains limited, highlighting a key area for further research to fully understand its distinct and overlapping roles with CD28 in T cell immunity (Wikenheiser & Stumhofer 2016).
Click on a node on the pathway to see its details. Glycoproteins are marked with a glycoprotein icon in their name.

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: [email protected]

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.5.0

Last updated: April 6, 2026